Absence of p53 Gene Mutations in Primary Neuroblastomas

Cancer Research

Volumn 53, Issue 21, 1993, Pages 5269-5273

  Vogan, Kyle ^a   Bernstein, Mark ^b   Leclerc, Jean Marie ^c   Brisson, Linda ^d   Brossard, Josee ^e   Brodeur, Garrett M ^f   Pelletier, Jerry ^a   Gros, Philippe ^a  

^a MCGILL UNIVERSITY   (Canada)

^b MONTREAL CHILDREN S HOSPITAL   (Canada)

^c UNIVERSITY OF MONTREAL   (Canada)

^d LAVAL UNIVERSITY   (Canada)

^e CENTRE HOSPITALIER UNIVERSITAIRE DE SHERBROOKE   (Canada)

^f WASHINGTON UNIVERSITY SCHOOL OF MEDICINE   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

TUMOR ANTIGEN;

AMINO ACID SUBSTITUTION; ARTICLE; CANCER INCIDENCE; CANCER MORTALITY; CANCER SCREENING; CANCER SURVIVAL; CHROMOSOME 17; CHROMOSOME ABERRATION; CLINICAL ARTICLE; DNA POLYMORPHISM; GENE MUTATION; GENE SEQUENCE; GENETIC ANALYSIS; HUMAN; HUMAN TISSUE; NEUROBLASTOMA; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; TUMOR SUPPRESSOR GENE;

BASE SEQUENCE; CHILD; CHROMOSOME ABERRATIONS; CHROMOSOMES, HUMAN, PAIR 17; CLONING, MOLECULAR; CODON; DNA PRIMERS; EXONS; GENES, P53; HUMAN; MOLECULAR SEQUENCE DATA; MUTATION; NEOPLASM STAGING; NEUROBLASTOMA; POLYMERASE CHAIN REACTION; POLYMORPHISM (GENETICS); SUPPORT, NON-U.S. GOV'T; SUPPORT, U.S. GOV'T, P.H.S.; TRISOMY;

EID: 0027434831     PISSN: 00085472     EISSN: 15387445     Source Type: Journal    
DOI: None     Document Type: Article

References (48)

1. Bernstein, M. L., Leclerc, J. M., Bunin, G., Brisson, L., Robison, L., Shuster, J., Byrne, T., Gregory, D., Hill, G., Dougherty, G., Scriver, C., Lemieux, B., Tuchman, M. and Woods, W. G. A population based study of neuroblastoma incidence, survival and mortality in North America. J. Clin. Oncol., 10: 323-329, 1992.
2. Hayes, F. A. and Smith, E. I. Neuroblastoma. In: P. A. Pizzo and D. G. Poplack (eds.), Principles and Practice of Pediatric Oncology, pp. 607-622. Philadelphia: J. B. Lippincott Co. 1989.
3. Shuster, J. J., Cantor, A. B., McWilliams, N., Pole, J. G., Castleberry, R. P., Marcus, R., Pick, T., Smith, E. I. and Hayes, F. A. The prognostic significance of autologous bone marrow transplant in advanced neuroblastoma. J. Clin. Oncol., 9: 1045-1049, 1991.
4. Sawada, T., Sugimoto, T., Kawakatsu, H., Matsumara, T. and Matsuda, Y. Mass screening for neuroblastoma in Japan. Pediatr. Hematol. Oncol., 8: 93-109, 1991.
5. Tuchman, M., Lemieux, B. Auray-Blais, C. Robison, L. L., Giguere, R., McCann, M. T. and Woods, W. G. Screening for neuroblastoma at 3 weeks of age: methods and preliminary results from the Quebec Neuroblastoma Screening Project. Pediatrics, 86: 765-772, 1990.
6. Woods, W. G., Tuchman, M., Bernstein, M. L., Leclerc, J. M., Brisson, L., Look, T., Brodeur, G. M., Shimada, H., Hann, H. L., Robison, L. L., Shuster, J. J. and Lemieux, B. Screening for neuroblastoma in North America: 2-year results from the Quebec Project. Am. J. Pediatr. Hematol. Oncol., 14: 312-319, 1992.
7. Look, A. T., Hayes, F. A., Shuster, J. J., Douglass, E. C., Castleberry, R. P., Bowman, L. C., Smith, E. I. and Brodeur, G. M. Clinical relevance of tumor cell ploidy and N-myc amplification in childhood neuroblastoma: a pediatric oncology group study. J. Clin. Oncol., 9: 581-591, 1991.
8. Levine, A. J., Momand, J. and Finlay, C. A. The p53 tumour suppressor gene. Nature (Lond.), 351: 453-456, 1991.
9. Linzer, D. I. H. and Levine, A. J. Characterization of a 54K dalton cellular SV40 tumor antigen present in SV40-transformed cells and uninfected embryonal carcinoma cells. Cell, 17: 43-52, 1979.
10. Levine, A. J. The p53 tumor-suppressor gene. N. Engl. J. Med., 326: 1350-1352, 1992.
11. Nigro, J. M., Baker, S. J., Preisinger, A. C., Jessup, J. M., Hostetter, R., Geary, K., Bigner, S. H., Davidson, N., Baylin, S., Devilee, P., Glover, T., Collins, F. C., Weston, A., Modali, R., Harris, C. C. and Vogelstein, B. Mutations in the p53 gene occur in diverse human tumor types. Nature (Lond.), 342: 705-708, 1989.
12. Hollstein, M., Sidransky, D., Vogelstein, B. and Harris, C. C.p53 mutations in human cancers. Science (Washington DC), 253: 49-53, 1991.
13. Caron de Fromentel, C. and Soussi, T. TP53 tumor suppressor gene: a model for investigating human mutagenesis. Genes Chromosomes Cancer, 4: 1-15, 1992.
14. Soussi, T. Caron de Fromentel, C. and May, P. Structural aspects of the p53 protein in relation to gene evolution. Oncogene, 5: 945-952, 1990.
15. Lowe, S., Schmitt, E. M., Smith, S. W., Osborne, B. A. and Jacks, T. p53 is required for radiation-induced apoptosis in mouse thymocytes. Nature (Lond.), 362: 847-849, 1993.
16. Brodeur, G. M., Green, A. A., Hayes, F. A., Williams, K. J., Williams, D. L. and Tsiatis, A. A. Cytogenetic features of human neuroblastomas and cell lines. Cancer Res., 41: 4678-4686, 1981.
17. Gilbert, F., Feder, M., Balaban, G., Brangman, D., Luric, D., Podolsky, R., Rinaldt, V., Vinikoor, N. and Weisband, J. Human neuroblastomas and abnormalities of chromosomes 1 and 17. Cancer Res., 44: 5444-5449, 1984.
18. Fong, C. T., Dracopoli, N. C., White, P. S., Merrill, P. T., Griffith, R. C., Housman, D. E. and Brodeur, G. M. Loss of heterozygosity for chromosome 1p in human neuroblastomas: correlation with N-myc amplification. Proc. Natl. Acad. Sci. USA, 86: 3753-3757, 1989.
19. Orita, M., Suzuki, Y., Sekiya, T. and Hayashi, K. Rapid and sensitive detection of point mutations and DNA polymorphisms using the polymerase chain reaction. Genomics, 5: 874-879, 1989.
20. Brodeur, G. M., Seeger, R. C., Barrett, A., Berthold, F., Castleberry, R. P. D'Angio, G. De Bernardi, B., Evans, A. E., Favrot, M., Freeman, A. I., Haase, G., Hartmann, O., Hayes, F. A., Helson, L., Kemshead, J., Lampert, F., Ninane, J., Ohkawa, H., Philip, T., Pinkerton, C. R., Pritchard, J., Sawada, T., Siegel, S., Smith, E. I., Tsuchida, Y. and Voute, P. A. International criteria for diagnosis, staging, and response to treatment in patients with neuroblastoma. J. Clin. Oncol., 6: 1874-1881, 1988.
21. Sambrook, J., Fritsch, E. F. and Maniatis, T. Molecular Cloning: A Laboratory Manual. Cold Spring Harbor, NY: Cold Spring Harbor Laboratory, 1989.
22. Murakami, Y., Hayashi, K. and Sekiya, T. Detection of aberrations of the p53 alleles and the gene transcript in human tumor cell lines by single-strand conformation polymorphism analysis. Cancer Res., 51: 3356-3361, 1991.
23. Pelletier, J., Bruening, W., Kashtan, C. E., Mauer, S. M., Manivel, J. C., Striegel, J. E., Houghton, D. C., Junien, C., Habib, R., Fouser, L., Fine, R. N., Silverman, B. L., Haber, D. A. and Housman, D. Germline mutations in the Wilms' tumor suppressor gene are associated with abnormal urogenital development in Denys-Drash syndrome. Cell, 67: 437-447, 1991.
24. Marchuk, D., Drumm, M., Saulino, A. and Collins, F. S. Construction of T-vectors, a rapid and general system for direct cloning of unmodified PCR products. Nucleic Acids Res., 19: 1154, 1991.
25. Sanger, F., Nicklen, S. and Coulson, A. R. DNA sequencing with chain-terminating inhibitors. Proc. Natl. Acad. Sci. USA, 74: 5463-5467, 1977.
26. von Deimling, A., Eibl, R. H., Ohgaki, H., Louis, D. N. von Ammon, K., Petersen, I., Kleihues, P., Chung, R. Y., Wiestler, O. D. and Seizinger, B. R. p53 mutations are associated with 17p allelic loss in grade II and grade III astrocytoma. Cancer Res., 52: 2987-2990, 1992.
27. Toguchida, J., Yamaguchi, T., Dayton, S. H., Beauchamp, R. L., Herrera, G. E., Ishizaki, K., Yamamuro, T., Meyers, P. A., Little, J. B., Sasaki, M. S., Weichselbaum, R. R. and Yandell, D. W. Prevalence and spectrum of germline mutations of the p53 gene among patients with sarcoma. N. Engl. J. Med., 326: 1301-1308, 1992.
28. Matlashewski, G. J., Tuck, S., Pim, D., Lamb, P., Schneider, J. and Crawford, L. V. Primary structure polymorphism at amino acid residue 72 of human p53. Mol. Cell. Biol., 7: 961-963, 1987.
29. Buchman, V. L., Chumakov, P. M., Ninkina, N. N., Samarina, O. P. and Georgiev, G. P. A variation in the structure of the protein-coding region of the human p53 gene. Gene (Amst.), 70: 245-252.
30. Brodeur, G. M., Azar, C., Brother, M., Hiemstra, J., Kaufman, B., Marshall, H., Moley, J., Nakagawara, A., Saylors, R., Scavarda, N., Schneider, S., Wasson, J., White, P., Seeger, R., Look, T. and Castleberry, R. Neuroblastoma: effect of genetic factors on prognosis and treatment. Cancer (Phila.), 70 (Suppl.): 1685-1694, 1992.
31. Srivatsan, E. S., Murali, V. and Seeger, R. C. Loss of heterozygosity for alleles on chromosome 11q and 14q in neuroblastoma. Prog. Clin. Biol. Res. 366:91-98,1991.
32. Suzuki, T., Yokota, J., Mugishima, H., Okabe, I., Ookuni, M., Sugimura, T. and Terada, M. Frequent loss of heterozygosity on chromosome 14q in neuroblastoma. Cancer Res., 49: 1095-1098, 1989.
33. Fong, C. T., White, P. S., Peterson, K., Sapienza, C., Cavanee, W. K., Kern, S. E., Vogelstein, B., Cantor, A. B., Look, A. T. and Brodeur, G. M. Loss of heterozygosity for chromosomes 1 or 14 defines subsets of advanced neuroblastomas. Cancer Res., 52: 1780-1785.
34. Chin, K. V., Ueda, K., Pastan, I. and Gottesman, M. M. Modulation of activity of the promoter of the human MDR1 gene by Ras and p53. Science (Washington DC), 255: 459-462, 1992.
35. Chan, H. S. L., Haddad, G., Thorner, P. S., DeBoer, G., Lin, Y. P., Ondrusek, N., Yeger, H. and Ling, V. P-glycoprotein expression as a predictor of the outcome of therapy for neuroblastoma. N. Engl. J. Med., 325: 1608-1614, 1991.
36. Davidoff, A. M., Pence, J. C., Shorter, N. A., Iglehart, J. D. and Marks, J. R. Expression of p53 in human neuroblastoma- and neuroepithelioma-derived cell lines. Oncogene, 7: 127-133, 1992.
37. Frankel, R. H., Bayona, W., Koslow, M. and Newcomb, E. W. p53 mutations in human malignant gliomas: comparison of loss of heterozygosity with mutation frequency. Cancer Res., 52: 1427-1433, 1992.
38. Fults, D., Brockmeyer, D., Tullous, M. W., Pedone, C. A. and Cawthon, R. M. p53 mutation and loss of heterozygosity on chromosomes 17 and 10 during human astrocytoma progression. Cancer Res., 52: 674-679, 1992.
39. Saxena, A., Clark, C., Robertson, J. T., Ikejiri, B., Oldfield, E. H. and Ali, I. U. Evidence for the involvement of a potential second tumor suppressor gene on chromosome 17 distinct from p53 in malignant astrocytomas. Cancer Res., 52: 6716-6721, 1992.
40. Ohgaki, H., Eibl, R. H., Wiestler, O. D., Yasargil, M. G., Newcomb, E. W. and Kleihaus, P. p53 mutations in nonastrocytic human brain tumors. Cancer Res., 57: 6202-6205, 1992.
41. Saylors, R. L., Sidransky, D., Friedman, H. S., Bigner, S. H., Bigner, D. D., Vogelstein, B. and Brodeur, G. M. Infrequent p53 gene mutations in medulloblastomas. Cancer Res., 57: 4721-4723, 1991.
42. Biegel, J. A., Burk, C. D., Barr, F. G. and Emanuel, B. S. Evidence for a 17p tumor related locus distinct from p53 in pediatric primitive neuroectodermal tumors. Cancer Res., 52: 3391-3395, 1992.
43. Spruck, C. H., Tsai, Y. C., Huang, D. P., Yang, A. S., Rideout, W. M. Gonzalez-Zulueta, M., Choi, P., Lo, K. W., Yu, M. C. and Jones, P. A. Absence of p53 gene mutations in primary nasopharyngeal carcinomas. Cancer Res. 52:4787-4790,1992.
44. Peng, H.-Q., Hogg, D., Malkin, D., Bailey, D. Gallic B. L., Bulbul, M., Jewett, M., Buchanan, J. and Goss, P. E. Mutations of the p53 gene do not occur in testis cancer. Cancer Res., 53: 3574-3578, 1993.
45. Heimdl, K., Lothe, R. A., Lystad, S., Holm, R., Fossa, S. D. and Borresen, A. L. No germline TP53 mutations detected in familial and bilateral testicular cancer. Genes Chromosomes Cancer, 6: 92-97, 1993.
46. Gutierrez, M. I., Bhatia, K., Siwarski, D., Wolff, L., Magrath, I. T., Mushinkski, J. F. and Huppi, K. Infrequent p53 mutation in mouse tumors with deregulated myc. Cancer Res., 52: 1032-1035, 1992.
47. Bader, S. A., Fasching, C., Brodeur, G. M. and Stanbridge, E. J. Dissociation of suppression of tumorigenicity and differentiation in vitro effected by transfer of single human chromosomes into human neuroblastoma cells. Cell Growth & Differ., 2: 245-255, 1991.
48. The, I., Murthy, A. E., Hannigan, G. E., Jacoby, L. B., Menon, A. G., Gusclla, J. F. and Bernards, A. Neurofibromatosis type 1 gene mutations in neuroblastoma. Nature Genet., 3: 62-66, 1993.